Cart
sales@molnova.com
Pelgifatamab
CAS No. 2414550-93-7
Pelgifatamab( —— )
Catalog No. M37700 CAS No. 2414550-93-7
Pelgifatamab (BAY-2315497) is a prostate-specific membrane antigen (PSMA) antibody with potential anticancer activity that can be used to study prostate cancer.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 453 | Get Quote |
|
| 5MG | 687 | Get Quote |
|
| 10MG | 937 | Get Quote |
|
| 25MG | 1371 | Get Quote |
|
| 50MG | 1812 | Get Quote |
|
| 100MG | 2421 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePelgifatamab
-
NoteResearch use only, not for human use.
-
Brief DescriptionPelgifatamab (BAY-2315497) is a prostate-specific membrane antigen (PSMA) antibody with potential anticancer activity that can be used to study prostate cancer.
-
DescriptionPelgifatamab (BAY-2315497) is a prostate-specific membrane antigen (PSMA) antibody with potential anticancer activity that can be used to study prostate cancer.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorPSMA
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2414550-93-7
-
Formula Weight
-
Molecular Formula——
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
46-Dioxoheptanoic ac...
46-Dioxoheptanoic acid is a potent inhibitor of heme biosynthesis.
-
B I09
B I09, an IRE-1 RNase inhibitor with an IC50 of 1230 nM, inhibits splicing of XBP1 mRNA in human WaC3 cells and expression of xbp-1 in LPS-stimulated B cells. B I09 can be used to simulate the defects of XBP-1 in CLL cells.
-
Platycoside E
Platycoside E?is a platycodigenin-type saponin isolated from the root of Platycodon grandiflorum with haemolytic activity and adjuvant potential.
